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Comparison of the anti-angiogenic potential of hydroxytyrosol 
and five derivatives  
Auxiliadora López-Jiménez
a
, Elena Gallardo
b
, José L. Espartero
b
, Andrés Madrona
b
, Ana R. 
Quesada
c,d 
and Miguel Ángel Medina
3
* 
Hydroxytyrosol is a phenolic compound present in extra virgin olive oil, either in free form or as derivatives, and related 
with some of the health benefits described for olive oil intake. We have demonstrated previously that hydroxytyrosol 
inhibits angiogenesis both in vitro and in vivo. In the present study, we evaluate the anti-angiogenic potential of five 
hydroxytyrosol derivatives. Three of these derivatives contain a nitro group and they exhibit a much weaker effect than 
hydroxytyrosol in the tubule formation assay on Matrigel and therfore were not studied further. In contrast, both 
hydroxytyrosyl acetate and ethyl hydroxytyrosyl ether show more potent inhibitory effects than hydroxytyrosol in both the 
in vitro tubule formation assay on Matrigel and the in vivo chorioallantoic membrane assay. Additionally, these three 
compounds had slight pro-apoptotic effects and decreased matrix metalloproteinase-2 levels in cell extracts. 
Introduction 
Addition of antioxidants (AO) to food is often necessary to 
avoid the oxidation of fatty moieties giving rise to the 
unpleasant rancid odor and taste, thus ensuring the food 
quality during processing and commercialization.1 In virgin 
olive oil (VOO), this addition is not necessary because of the 
presence of hydroxytyrosol (3,4-dihydroxyphenylethanol, HT, 
1) (Figure 1) and its derivatives, which are the main 
responsible of the high oxidative stability of VOO.2 In the last 
years, scientific evidence has accumulated pointing to the 
pleiotropic effects of HT on multiple targets. In fact, 
demonstrated beneficial effects of HT for human health 
include its antidiabetic,3,4 antifungal,5 antiinflammatory,6 anti-
parasitic,7 cardio-8 and neuroprotective9 activities. HT has also 
beneficial effects on metabolic syndrome10 and antitumoral 
effects of HT have been reported.11,12  
On the other hand, HT has been shown to be an anti-
angiogenic compound able to inhibit several key steps in the 
angiogenic process.13 In fact, HT can behave as a protective 
compound against angiogenesis-dependent diseases, as in the 
case of rheumatoid arthritis.14 The anti-angiogenic potential of 
HT is due to its shown inhibitory effects on multiple molecular 
targets, including inhibition of matrix metalloproteinase 2 
(MMP-2),
15
 MMP-9, cyclooxygenase 2 and vascular endothelial 
growth factor receptor-2 (VEGFR-2) phosphorylation.
6,16
 
Additional protective effects of HT against endothelial cell 
dysfunction have been reported.
8
  
However, the hydrophilic nature of HT prevents its direct use 
in the protection of lipidic matrices. Currently available natural 
lipophilic AO are barely tocopherols and β-carotene, whereas 
synthetic ones, such as propyl gallate (PG), butylated 
hydroxyanisole (BHA), butylated hydroxytoluene (BHT) or tert-
butylhydroquinone (TBHQ), have not shown to be completely 
safe.
17
 For this reason, there is an increasing interest in the 
food industry to develop new lipophilic AO for use as 
functional ingredients in lipid food matrices. In this sense, 
several lipophilic HT derivatives have been prepared, among 
them: esters,
18
 ethers,
19
 nitro,
20,21
 and isochroman-
derivatives,
22
 which have shown antioxidant activities, at least, 
as efficient as that of HT itself,
18,22-24
 with improved physico-
chemical properties regarding lipid solubility and miscibility. 
Recent reviews on the subject have been published.
25,26
  
Some of these HT derivatives are particularly interesting.
 
Thus, 
HT acetate (2, Figure 1) is an antioxidant naturally present in 
olive oils
27 
that is transported across the small intestinal 
epithelial cell barrier more efficiently than HT,
28
 showing 
higher hepatic bioavailability than HT.
29
 Moreover, 2 has 
shown protective effects against oxidative DNA damage in 
blood cells,
30
 iron-induced oxidative stress in human cervical 
cells,
31
 oxidative stress in HepG2 cells
32
 and a significant 
improvement in the oxidative state of human red blood cells.
33
 
In addition, HT ethyl ether (3, Figure 1),
19
 with an alkyl chain of 
the same length as the acyl chain in 2, was included in this 
study to assess the influence of different functional groups 
(ether vs ester) on the biological activity of the two phenolic 
compounds. 3 is also absorbed to a higher extent in Caco-2 
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cells than its precursor HT,
34
 being also broadly taken up by 
HepG2 cells.
35
 In addition, 3 protects hepatic human HepG2 
cells against oxidative stress
36
 and inhibits platelet activation 
after oral administration in rats.
37
 Recently, beneficial 
metabolic effects of these HT hydrophobic derivatives, 2 and 3, 
in hypercholesterolemic rats have been shown.
38
 
Otherwise, introduction of a nitro group (NO2) in the 
cathecolic ring of HT induces a significant increase in their 
antioxidant activities,
20,21
 maintaining a high in vitro 
bioavailability and hepatic metabolism.
39
 Finally, a recent 
study has shown that some nitroderivatives associated with 
the Mediterranean diet have an important cardioprotective 
effect.
40 
For these reasons, nitro homologues (compounds 4-6, 
Figure 1) of above were selected for inclusion in this research. 
Taking into account all this background, the aim of the present 
work was to study the potential anti-angiogenic effects of five 
HT derivatives, namely compounds 2-6, using free HT (1) as 
standard reference. All selected compounds in this work 
maintain the ortho-diphenolic group intact and show higher 
antioxidant capacity than HT itself, preserving their potential 
application as antioxidants to stabilize foodstuffs or as 
functional food ingredients. 
 
Materials and methods 
Chemicals 
Supplements and other chemicals not listed in this section 
were obtained from Sigma Chemicals Co. (St. Louis MO, USA). 
Cell culture media, penicillin, streptomycin and amphotericin 
were purchased from Biowhittaker (Walkersivlle, MD, USA). 
Fetal bovine serum (FBS) and human serum (HS) were 
products of Harlan-Seralb (Belton, United Kingdom). Plastics 
for cell culture were supplied by NUNC (Rockilde, Denmark) 
and VWR (West Chester, Pennsylvania, USA). Hydroxytyrosol 
derivatives used in the present work were hydroxytyrosyl 
acetate (2), ethyl hydroxytyrosyl ether (3), nitrohydroxytyrosol 
(4), nitrohydroxytyrosyl acetate (5), and ethyl 
nitrohydroxytyrosyl ether (6). HT derivatives were synthesized 
as previously described elsewhere.
18-21
 As a control, free HT (1) 
was also tested. HT (>99%) was supplied by Seprox Biotech 
(Murcia, Spain). Figure 1 shows the chemical structure of the 
six tested compounds. 
 
Cell culture 
Bovine aorta endothelial cells (BAEC) were isolated from 
bovine aortic arches, as previously described,
41
 and 
maintained in Dulbecco´s modified Eagle´s medium (DMEM) 
containing glucose (1 g/L), glutamine (2 mM), penicillin (50 
IU/mL), streptomycin (50 mg/ L), amphotericin (1.25 mg/L), 
10% fetal bovine serum. 
 
Control assays of in vitro toxicity 
With the exception of the in vitro MTT cell growth and the cell 
survival assays, the rest of the in vitro assays used in this study 
were carried out under conditions (hydroxytyrosol derivative 
concentrations and duration of treatments) that produced no 
cytotoxic effect on cells. This lack of cytotoxicity was 
determined by modified MTT survival assays, that is, MMT 
assays carried out at the same concentrations and duration of 
treatments used in the rest of the in vitro assays described in 
this study (routinary control results not shown). 
 
MTT cell growth assay 
The 3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium 
bromide (MTT) dye reduction assay in 96-well microplates was 
used. The assay is dependent on the reduction of MTT by 
mitochondrial dehydrogenases of viable cells to a blue 
formazan product, which can be measured 
spectrophotometrically. BAEC (2.5x10
3
 cells in a total volumen 
of 100 μL of complete medium) were incubated in each well 
with serial dilutions of HT derivatives. After 3 days of 
incubation in the dark (37°C, 5% CO2 in a humid atmosphere), 
10 μL of MTT (5mg/mL in PBS) was added to each well, and the 
plate was incubated for a further 4 h (37°C). The formazan was 
dissolved in 150 μM of 0.04 N HCl-2 propanol, and samples 
were spectrophotometrically measured at 550 nm. All 
determinations were carried out in quadruplicate, and at least 
three independent experiments were carried out. IC50 values 
were calculated as those concentrations of compound yielding 
50% cell survival, taking the values obtained for control as 
100%.  
 
Endothelial cell differentiation assay: tube formation on Matrigel  
Wells of 96-well microplate were coated with 50 µL of Matrigel 
(10.5 mg/mL) at 4 °C and allowed to polymerize at 37 °C for a 
minimum of 30 min. Some 5 × 104 BAE cells were added in 200 
µL of complete medium. Finally, different amounts of HT 
derivatives were added and incubated at 37 °C in a humidified 
chamber with 5% CO2. After incubation for 7 h, cultures were 
observed and photographed with a Nikon DIAPHOT-TMD 
inverted microscope (Tokyo, Japan). Each concentration was 
tested in triplicate, and two different observers evaluated the 
results of chord formation inhibition. Those assays where no 
tubular structure could be observed were considered as 
positive in this assay. The minimal concentration required for 
this complete inhibitory effect will be referred as MIC (minimal 
inhibitory concentration).  
 
Cell cycle analysis by flow cytometry 
Cells at > 80% of confluence in 6-well plates were treated with 
different concentrations of tested compounds for 24 h. After 
incubation, attached and unattached HT derivative-treated 
and control cells were harvested, washed (PBS), and fixed 
(70% ethanol, 1 h on ice). Pelleted cells were incubated with 
RNase A (o.1 mg/mL) and propidium iodide (40 μg/mL) for 1 h 
with shaking and protected from light. Percentages of sub-G1, 
G1 and G2/M populations were determined using a Dako 
MoFlow cytometer and its software, Summit 4.3. 
 
 Hoechst staining of nuclei to detect apoptotic cells 
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Cells were seeded on 8-well chamber slides and grown to sub-
confluence. After treatments with the indicated 
concentrations of HT derivatives for 14 h, cells were washed 
(PBS) and fixed (formalin solution, Sigma). Chamber slides 
were stained with Hoechst, mounted (DAKO Cytomation 
Fluorescent Mounting Medium, DAKO), and observed under a 
fluorescence microscope (Leica, TCS-NT).  
 
Gelatinolytic activity  
To prepare conditioned media and cell lysates, BAEC were 
grown at 75% confluency in 6-well plates. After 2 washes with 
PBS, each well received the indicated concentration of HT 
derivatives in 1.5 mL of DMEM/0.1% bovine serum albumin 
(BSA) containing 200 kallikrein inhibitor units (KIU) of 
aprotinin/mL. After 24 h of incubation, the conditioned media 
were collected, and the cells were washed twice with PBS and 
harvested by scrapping into 0.5 mL of 0.2% Triton X-100 in 0.1 
M Tris/HCl containing 200 KIU of aprotinin. Duplicates were 
used to determine the cell number by using a Coulter counter. 
The media and cell lysates were centrifuged at 1000× g at 4 °C 
for 20 min, and the supernatants were collected and used for 
assayed gelatinolytic activity. 
The gelatinolytic activities of MMP-2 delivered to the 
conditioned media or present in cell lysates were detected in 
gelatinograms. Aliquots of conditioned media and cell lysates 
normalized for equal cell numbers were subjected to non-
reducing SDS-PAGE with gelatin (1 mg/mL) added to the 10% 
resolving gel. After electrophoresis, gels were washed twice 
with 50 mM Tris/HCl, pH 7.4, supplemented with 2% Triton X-
100, and twice with 50 mM Tris/HCl, pH 7.4. Each wash was for 
10 min and with continuous shaking. After the washes, the gels 
were incubated overnight at 37 °C immersed in a substrate 
buffer (50 mM Tris/HCl, pH 7.4, supplemented with 1% Triton 
X-100, 5 mM CaCl2 and 0.02% Na3N). Then, the gels were 
stained with Commassie Blue R-250, and the bands of 
gelatinase activity could be detected as non-stained bands in a 
dark, stained background. Quantitative analysis of 
gelatinograms was performed with the NIH Image 1.6 
program. 
 
In vivo chorioallantoic membrane (CAM) assay  
Fertilized chick eggs were incubated horizontally at 38°C in a 
humidified incubator, windowed by day 3 of incubation and 
processed by day 8. The indicated amount of HT derivatives 
was added to a 1% solution of methylcellulose in water, and 10 
μL drops of this solution were allowed to dry on a Teflon-
coated surface in a laminar flow hood. Then, the 
methylcellulose disks were implanted on the CAMs, and the 
eggs were sealed with adhesive tape and returned to the 
incubator for 48 h. Negative controls were always made with 
ethanol (vehicle) mixed with methylcellulose. After the 
reincubation, CAMs were examined under a stereomicroscope. 
The assay was scored as positive when two independent 
observers reported a significant reduction of vessels in the 
treated area.  
 
Statistical analysis  
For all of the assays, at least three independent experiments 
were carried out. Results are expressed as means ± SD. 
Statistical significance was determined by using Student´s 
paired simple test. Values of p<0.05 were considered to be 
significant.  
Results 
HT derivatives have inhibitory effects on the growth of BAEC 
Since many of the described anti-angiogenic compounds were 
firstly selected by their inhibitory effect on endothelial cell 
proliferation and HT has been reported to inhibit endothelial 
cell growth with IC50 values within the micromolar range,
13
 we 
firstly tested the ability of HT derivatives to inhibit the 
proliferation of actively growing BAEC. Table 1 shows that IC50 
values for four out of the five tested HT derivatives are lower 
than that of free HT. 
 
HT derivative compounds 2 and 3 have a very potent inhibitory 
effect on the capillary tube formation by BAEC 
The formation of a three-dimensional network of tubes by 
endothelial cells and its stabilization by recruiting pericytes are 
key events at the end of angiogenesis. In vitro, endothelial cells 
plated on Matrigel align themselves forming cords enclosing 
void spaces. This is the case for control, untreated BAEC shown 
in Figure 2. Compounds that inhibit this process totally without 
affection of cell viability give rise to small rounded patches of 
viable cells isolated from each other. The MIC for HT 
(compound 1) in this assay was 250 µM. Figure 2 shows that 
250 µM of compounds 4, 5 and 6 was not enough to 
completely inhibit tube formation by BAEC. In contrast, 
compounds 2 and 3 exhibited much stronger inhibitory effects 
than HT, with their MICs as low as 30 and 15 µM, respectively. 
Based on the results obtained with this key assay, we decided 
to test the rest of the assays only with compounds 1, 2 and 3. 
 
HT derivatives 2 and 3 exhibit mild pro-apoptotic effects on BAEC 
The distribution of cell subpopulations in the different phases 
of cell cycle can be easily assessed in propidium iodide stained 
cells by flow cytometry. Figure 3A shows that HT (compound 
1), HT acetate (compound 2) and ethyl HT ether (compound 3) 
slightly increased the percentage of BAEC at the subG1 phase, 
suggesting their potential pro-apoptotic effects on endothelial 
cells. Hoechst dye staining of nuclei shows that compound 3 
exhibited mild pro-apoptotic effects on a mean percentage of 
BAEC higher than HT (Figure 3B and Table 2).  
 
HT derivatives 2 and 3 exhibit inhibitory effects on BAEC MMP-2 
similar to those induced by free HT 
We have previously shown that HT decreases the MMP-2 levels 
secreted to BAEC conditioned medium in a dose dependent 
manner.
13
 Table 3 shows that compounds 1, 2 and 3 produced 
similar decreases in the MMP- 2 levels in BAEC conditioned media 
and cell extracts. 
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HT derivatives 1 and 3 inhibit in vivo angiogenesis 
Table 4 summarizes the results obtained with the CAM assay. Both 
HT derivatives, HT acetate (2) and ethyl HT ether (3) were stronger 
inhibitors of angiogenesis than compound 1 (free HT). Positive, 
inhibitory effects were observed in 100% of eggs treated with 200 
nmol of 2, 86% of eggs treated with 200 nmol of 3 and 53% of eggs 
treated with 200 nmol of free HT (1). 
Discussion 
As mentioned in the Introduction, HT exhibits pleiotropic effects on 
multiple targets related with many physiopathologic conditions. 
Available data suggest potential pharmacological uses of this 
compound and underscore the chemopreventive roles it might play. 
Based on these grounds, diverse HT derivatives have been 
synthesized.
18-22
 The bioactivities of these HT derivatives have been 
studied, including their antiplatelet aggregation capacity,
4,42,43
 
neuroprotective activity,44 DNA oxidative damage protection,30 
cytoprotection,
45
 antiinflammatory effects,
38,46
 and anticancer 
activity.
12,47
 Most of these derivatives have shown to maintain or 
even improve the diverse activities of free HT, mainly due to the 
better lipophilic/hydrophilic balance exhibited by these 
derivatives.
25
 
Our group has previously shown that HT behaves as an anti-
angiogenic compound both in vitro and in vivo.
13,15
 It should be 
underscored that these effects were observed with HT doses within 
the range of those absorbed from a sustained, moderate intake of 
VOO, like in a typical Mediterranean diet.
48
 Important molecular 
targets for the antiangiogenic effect of HT are VEGFR-2,
16
 and 
extracellular remodeling enzymes.13,15 The anti-angiogenic effects 
of HT suggest that it might be protective against angiogenesis-
dependent diseases, as it seems to be the case for age-related 
macular degeneration and rheumatoid arthritis.
14,49
  
In spite of the fact that numerous HT derivatives have been so far 
described, up to now their anti-angiogenic potential has not been 
yet studied. In the present study, we have tested five HT 
compounds and we have compared their anti-angiogenic potential 
with that exhibited by free HT. Endothelial cells use to be quiescent 
in the adult. In contrast, they quickly become proliferative when the 
angiogenic phenotype is switched on. Any compound able either to 
inhibit endothelial cell proliferation or to induce endothelial cell 
death could be considered as a potential antiangiogenic compound. 
This is the case of HT and its five derivatives tested in the present 
study. It should be mentioned that the IC50 value for HT shown in 
Table 1 is almost half of that IC50 value reported for HT on BAEC in 
our previous article.13 Perhaps this difference is due to the different 
suppliers (Extrasynthèse versus Seprox Biotech) and declared purity 
(98% versus 99%) of the HT samples used in the previous and the 
present work, respectively.  
The formation of tubule-like structures by endothelial cells on 
Matrigel simulates the key final step of the angiogenic process. The 
assay is as sensitive and selective as to be useful for a primary 
screening of antiangiogenic compounds.
50
 Our data clearly show 
that both compounds 2 and 3 behave as much more potent 
inhibitors than free HT (1) in this assay, decreasing the MIC values 
from 250 μM for HT to 30 and 15 μM for compounds 2 and 3, 
respectively. In contrast, tested compounds containing a nitro 
group (compounds 4-6) exhibited much weaker effects than HT, as 
shown by the fact that none of these three nitro-containing HT 
derivatives tested at 250 μM could abrogate tube formation on 
Matrigel. For this reason, compounds 4-6 were no longer analyzed 
in the present work. The presence in the cathecolic ring of an 
electron-withdrawing substituent as the NO2 group, undoubtedly 
decrease the biological activity of these compounds, similarly to 
previously reported results for other phenolics compounds,
51,52
 
although these compounds have shown a good antioxidant activity 
in chemical media.
20,21
 
We had previously shown that 0.5-1 mM HT treatment increased 
the sub-G1 population of immortalized human umbilical vein 
endothelial ECRF-24 cells.
13
 In the present work, we confirm this 
effect showing that 0.5 mM HT also increased the sub-G1 
population in BAEC treated cells. Similar effects were obtained in 
BAEC treated with 0.5 mM of either compound 2 or compound 3. 
These data suggest that these three compounds could have mild 
proapoptotic effects on BAEC, as confirmed by Hoechst staining of 
nuclei. 
To invade its surroundings during angiogenesis, endothelial cells 
have to produce increased levels of the extracellular matrix 
remodeling enzymes, mainly MMP-2 and uPA. We have recently 
published qPCR data regarding the effects of 1 mM HT treatment 
(24 h) on BAEC messenger RNA expression levels of extracellular 
matrix remodeling enzymes and their inhibitors.
15
 Those published 
data clearly showed that MMP-2 and uPA levels, as well as MMP-
2/TIMPs ratios were decreased by HT, which suggested that this 
compound could decrease the invasive potential of endothelial 
cells. In the present work, we confirm and extend that previous 
observation. In fact, herein we show that the three selected 
compounds 1-3 decreased the levels of MMP-2 secreted to BAEC 
conditioned media and present in BAEC cell extracts. The inhibitory 
effects of compound 3 on MMP-2 in BAEC conditioned media and 
cell extracts seem to be complementary (minimum effect in 
conditioned media samples and maximum effect in cell extract 
samples). 
The CAM assay is the most frequently used in vivo assay of 
angiogenesis.
53
 The results obtained in this in vivo angiogenesis 
assay confirm that hydroxytyrosol (compound 1), hydroxytyrosyl 
acetate (compound 2) and ethyl hydroxytyrosyl ether (compound 3) 
are inhibitors of angiogenesis, with compound 2 exhibiting the most 
potent effect. 
Conclusions 
Taken altogether, the results presented in this work confirm that HT 
is an anti-angiogenic compound and they show for the first time 
that two HT derivatives, namely, HT acetate (compound 2) and 
ethyl HT ether (compound 3) can be considered new anti-
angiogenic compounds with more potent inhibitory effects in both 
the in vitro tubule formation assay on Matrigel and the in vivo CAM 
assay. These new results add interest to the presence of compound 
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2 in VOO and to the potential use of compounds 2 and 3 as 
functional food ingredients. 
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Figure 2  
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Figure 3  
 
254x190mm (72 x 72 DPI)  
 
 
Page 9 of 9 Food & Function
Fo
od
&
Fu
nc
tio
n
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
04
 Ju
ly
 2
01
8.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
id
ad
 d
e 
M
al
ag
a 
on
 7
/4
/2
01
8 
1:
07
:0
4 
PM
. 
View Article Online
DOI: 10.1039/C8FO01140K
